These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18309933)

  • 1. Synthesis of cell-penetrating peptides and their application in neurobiology.
    Dietz GP; Bähr M
    Methods Mol Biol; 2007; 399():181-98. PubMed ID: 18309933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transduction of peptides and proteins into live cells by cell penetrating peptides.
    Mussbach F; Franke M; Zoch A; Schaefer B; Reissmann S
    J Cell Biochem; 2011 Dec; 112(12):3824-33. PubMed ID: 21826709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide-enhanced cellular internalization of proteins in neuroscience.
    Dietz GP; Bähr M
    Brain Res Bull; 2005 Dec; 68(1-2):103-14. PubMed ID: 16325010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the use of cell-penetrating peptides for medical and biological applications.
    Fonseca SB; Pereira MP; Kelley SO
    Adv Drug Deliv Rev; 2009 Sep; 61(11):953-64. PubMed ID: 19538995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-penetrating peptides: Nanocarrier for macromolecule delivery in living cells.
    Chugh A; Eudes F; Shim YS
    IUBMB Life; 2010 Mar; 62(3):183-93. PubMed ID: 20101631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transduced human PEP-1-heat shock protein 27 efficiently protects against brain ischemic insult.
    An JJ; Lee YP; Kim SY; Lee SH; Lee MJ; Jeong MS; Kim DW; Jang SH; Yoo KY; Won MH; Kang TC; Kwon OS; Cho SW; Lee KS; Park J; Eum WS; Choi SY
    FEBS J; 2008 Mar; 275(6):1296-308. PubMed ID: 18279381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acidic peptide-mediated expression of the antimicrobial peptide buforin II as tandem repeats in Escherichia coli.
    Lee JH; Minn I; Park CB; Kim SC
    Protein Expr Purif; 1998 Feb; 12(1):53-60. PubMed ID: 9473457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Construction and functional study of a cell penetrating peptide-based expression vector for targeted delivery of proteins into the cell nuclei].
    Li HY; Guo AH; Liu ZF; Liu Y; Liu JH; Deng P; Li ZJ; Liu YW; Jiang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Oct; 26(10):1394-9, 1407. PubMed ID: 17062334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of the aggregate inhibitor peptide QBP1 into the mouse brain using PTDs and its therapeutic effect on polyglutamine disease mice.
    Popiel HA; Nagai Y; Fujikake N; Toda T
    Neurosci Lett; 2009 Jan; 449(2):87-92. PubMed ID: 18603372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of human and mouse recombinant alpha-fetoproteins expressed in Escherichia coli.
    Boismenu R; Semeniuk D; Murgita RA
    Protein Expr Purif; 1997 Jun; 10(1):10-26. PubMed ID: 9179285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-penetrating peptides in drug development: enabling intracellular targets.
    Chen L; Harrison SD
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):821-5. PubMed ID: 17635156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic engineering of mammalian cells by direct delivery of FLP recombinase protein.
    Patsch C; Kesseler D; Edenhofer F
    Methods; 2011 Apr; 53(4):386-93. PubMed ID: 21185381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The many futures for cell-penetrating peptides: how soon is now?
    Howl J; Nicholl ID; Jones S
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):767-9. PubMed ID: 17635144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of dementia induced by Aβ 22-35 through rectal delivery of undecapeptide-hEGF to mouse brain.
    Zhao BQ; Guo YR; Li XL; Zang T; Qu HY; Zhou JP; Li Q; Sun MJ
    Int J Pharm; 2011 Feb; 405(1-2):1-8. PubMed ID: 21093564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of cell-penetrating peptides as vectors for drug delivery].
    Ren J; Qin CG; Xu CL; Wang QY; Zuo XJ
    Yao Xue Xue Bao; 2010 Jan; 45(1):17-25. PubMed ID: 21351444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic applications of cell-penetrating peptides.
    Johnson RM; Harrison SD; Maclean D
    Methods Mol Biol; 2011; 683():535-51. PubMed ID: 21053155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transduction peptides: from technology to physiology.
    Joliot A; Prochiantz A
    Nat Cell Biol; 2004 Mar; 6(3):189-96. PubMed ID: 15039791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The augmentation of intracellular delivery of peptide therapeutics by artificial protein transduction domains.
    Yoshikawa T; Sugita T; Mukai Y; Abe Y; Nakagawa S; Kamada H; Tsunoda S; Tsutsumi Y
    Biomaterials; 2009 Jul; 30(19):3318-23. PubMed ID: 19304319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Break on through to the other side-biophysics and cell biology shed light on cell-penetrating peptides.
    Fischer R; Fotin-Mleczek M; Hufnagel H; Brock R
    Chembiochem; 2005 Dec; 6(12):2126-42. PubMed ID: 16254940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier.
    Pardridge WM; Boado RJ
    Methods Enzymol; 2012; 503():269-92. PubMed ID: 22230573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.